Lineage Cell Therapeutics Patents – Key Insights and Stats

Lineage Cell Therapeutics has a total of 859 patents globally, out of which 398 have been granted. Of these 859 patents, more than 41% patents are active. United States of America is where Lineage Cell Therapeutics has filed the maximum number of patents, followed by Australia and countries of Europe, it has generated an annual revenue of $3.89 million in the year 2021. Parallelly, the USA seems to be the main focused R&D centre and is also the origin country of Lineage Cell Therapeutics.

Lineage Cell Therapeutics was founded in the year 1990 by Judith Segall, Michael D West and Paul Segall. The firm is a clinical-stage biotechnology firm focused on creating innovative cell treatments to address unmet medical needs. As of April 2022, Lineage Cell Therapeutics has a market cap of $0.23 Billion.

Do read about some of the most popular patents of Lineage Cell Therapeutics which have been covered by us in this article and also you can find Lineage Cell Therapeutics’ patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Lineage Cell Therapeutics’ patent portfolio.

How many patents does the CEO of Lineage Cell Therapeutics have?

The CEO, Brian Culley, has 3 patents.

How many patents does Lineage Cell Therapeutics have?

Lineage Cell Therapeutics has a total of 859 patents globally. These patents belong to 123 unique patent families. Out of 859 patents, 360 patents are active.

How Many Patents did Lineage Cell Therapeutics File Every Year?

Lineage Cell Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantLineage Cell Therapeutics Applications FiledLineage Cell Therapeutics Patents Granted
20112516
20122620
20132019
20141119
20156133
20165416
20173731
20184515
20191728
20201918
20211620
20223

How many Lineage Cell Therapeutics patents are Alive/Dead?

Worldwide Patents

Lineage Cell Therapeutics Patent Portfolio

How Many Patents did Lineage Cell Therapeutics File in Different Countries?

Lineage Cell Therapeutics Worldwide Patent Filing

Countries in which Lineage Cell Therapeutics Filed Patents

CountryPatents
United States Of America218
Australia96
Europe75
Japan72
Canada57
Singapore49
Israel48
United Kingdom40
China34
Hong Kong (S.A.R.)31
Korea (South)23
Germany20
India13
Spain9
Brazil4
Eurasian4
Mexico3
Philippines2
Denmark2
South Africa2
New Zealand2
Czech Republic1
Yugoslavia/Serbia and Montenegro1
Argentina1

Where are Research Centres of Lineage Cell Therapeutics Patents Located?

Lineage Cell Therapeutics R&D Centre

10 Best Lineage Cell Therapeutics Patents

US6800480B1 is the most popular patent in the Lineage Cell Therapeutics portfolio. It has received 425 citations so far from companies like Reliance Life Sciences, Geron Corporation, and Industrial Technology Research.

Below is the list of 10 most cited patents of Lineage Cell Therapeutics:

Publication NumberCitation Count
US6800480B1425
US20030224411A1397
US6642048B2375
US20020072117A1373
US6458589B1320
US6833269B2278
US7326572B2239
US7033831B2232
US6506574B1160
US6440735B1151

Which Companies are using Lineage Cell Therapeutics Patents to Advance their Research?

If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.

The top citing companies in the Lineage Cell Therapeutics patent portfolio are Asterias Biotherapeutics, Procella Therapeutics, and Kaneka Corporation.

List of the top forward citing Companies –

CompanyNumber of Patents
Procella Therapeutics Ab1
Asterias Biotherapeutics1
The Brigham And Women’S Hospital Inc1
Accelerated Biosciences Corp1
Cambridge Enterprise Limited1
Regenerative Research Foundation1
City Of Hope1
StemRD1
Corning1
Kaneka Corporation1

Count of 102 and 103 Type Rejections based on Lineage Cell Therapeutics Patents

Top Lineage Cell Therapeutics Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US20060194321A14
US20050095708A12
US20040253721A12
US8148151B21
US20180325958A11
US6875607B11
US7604990B21
US20090263835A11
US20100248366A11
US20160362661A11

The firm is working on anti-ageing technology and is backed by BlackRock, Raffles Capital Management, Wells Fargo, and others.

EXCLUSIVE INSIGHTS COMING SOON!

What are Lineage Cell Therapeutics’ key innovation segments?

What Technologies are Covered by Lineage Cell Therapeutics?

The chart below distributes patents filed by Lineage Cell Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Lineage Cell Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Lineage Cell Therapeuticssearch focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Lineage Cell Therapeutics?

Table of Content

Insights you may find interesting

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.